EN PL
CASE REPORT
Organising pneumonia – the first manifestation of rheumatoid arthritis
 
More details
Hide details
 
Submission date: 2017-09-19
 
 
Final revision date: 2017-10-25
 
 
Acceptance date: 2017-11-27
 
 
Online publication date: 2017-12-30
 
 
Publication date: 2017-12-31
 
 
Reumatologia 2017;55(6):314-317
 
KEYWORDS
TOPICS
ABSTRACT
Organising pneumonia (OP) is a distinct type of interstitial lung disease, because it can also be seen in association with several conditions such as infections, drugs, and connective tissue diseases. An association of OP with rheumatoid arthritis (RA) has also been described. Joint manifestations of RA usually precede lung involvements by several years; however, in less than 10% of cases of RA, interstitial lung disease may be the initial feature of RA. Organising pneumonia as the initial manifestation or developed simultaneously of RA is extremely rare, and its clinical features remain unknown. We present a 56-year-old woman with OP as the first manifestation of RA.
 
REFERENCES (17)
1.
Cimmino MA, Salvarini C, Macchioni P, et al. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 2000; 19: 213-217.
 
2.
Turesson C, O’Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003; 62: 722-727.
 
3.
Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest 2011; 140: 1292-1299.
 
4.
Tsuchiya J, Takayanagi N, Sigiura H, et al. Lung disease directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 2011; 37: 1411-1417.
 
5.
Mori S, Cho I, Koga J, Sugimoto M. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 2008; 35: 1513-1521.
 
6.
Doyle TJ, Dellaripa PF, Batra K, et al. Functional impact of a spectrum of interstial lung abnormalities in rheumatoid arthritis. Chest 2014; 146: 41-50.
 
7.
Zou YQ, Li YS, Ding XN, Ying ZH. The clinical significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease: a report from China. Rheumatol Int 2012; 32: 669-673.
 
8.
Lee HK, Kim DS, Joo B, et al. Histopathological pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005; 127: 2019-2027.
 
9.
Kim EJ, Collard HR, King TE. Rheumatoid arthritis-associated ILD: the relevance of histopathological and radiographic pattern. Chest 2009; 136: 1397-1405.
 
10.
Colby TV. Pathological aspects of bronchiolitis obliterans organizing pneumonia. Chest 1992; 102; 38-43.
 
11.
Mori S, Cho I, Koga J, et al. A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature. Mod Rheumatol 2008; 18: 60-66.
 
12.
Baque-Juston M, Pellegrin A, Leroy S, et al. Organizing pneumonia: What is it? A conceptual approach and pictorial review. Diagn Interv Imaging 2014; 95: 771-777.
 
13.
Izumi T, Kitaichi M, Nishimura K, et al. Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest 1992; 102; 715-719.
 
14.
Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004; 232: 81-91.
 
15.
Hoshino C, Satoh N, Narita M, et al. Organizing pneumonia as the first manifestation of rheumatoid arthritis. BMJ Case Reports 2011; 2011: pii: bcr1120103558.
 
16.
Lee DM, Schur Ph. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003; 62: 870-874.
 
17.
Mori S. Management of rheumatoid arthritis patients with interstitial lung disease: Safety of Biological antirheumatic drugs and assessment of pulmonary fibrosis. Clin Med Insights Circ Respir Pulm Med 2015; 9: 41-49.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top